Clinical trial
A Clinical Research Study Testing Ropinirole Treatment for Restless Legs…
NCT00363857 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00363857 |
|---|---|
| Title | A Clinical Research Study Testing Ropinirole Treatment for Restless Legs Syndrome |
| Official title | A 12-Week, Double-Blind, Placebo Controlled, Parallel Group Study to Assess the Efficacy and Safety of Ropinirole in Patients Suffering From Restless Legs Syndrome (RLS) |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Restless Legs Syndrome (RLS), Restless Legs Syndrome |
| Intervention type | Drug |
| Interventions | Ropinirole |
| Enrollment | 360 |
| Start date | Aug 1, 2003 |
| Primary completion | May 1, 2004 |
| Completion | May 1, 2004 |
| First posted | Aug 15, 2006 |
| Last update posted | Oct 17, 2016 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: